Lonny S. Green, MDObstetrics and Gynecology
Lonny S. Green, M.D., received his Bachelor of Science in biology from Stanford University. He earned his medical degree from UCLA School of Medicine. Dr. Green completed his second year of general surgery at Brigham & Women’s Hospital in Boston. He then completed the Harvard Program in Urology, through Brigham & Women’s Hospital, Beth Israel Hospital, Children’s Hospital and West Roxbury Veteran’s Hospital.
Dr. Green completed postgraduate training at Monash University in Melbourne, Australia where he served as senior registrar at the Alfred Hospital. He holds a Master of Business Administration from the University of St. Thomas in Minnesota. He is also an associate clinical professor with the Department of Surgery for the Medical College of Virginia Hospitals.
Dr. Green has received numerous honors and scholarships. He has authored many articles in his field of study and has presented in the U. S. and abroad. Dr. Green is a diplomate of the American Board of Urology as well as the National Board of Medical Examiners. He is a member of the American Urological Association, the International Continence Society, the Richmond Academy of Medicine, la Societe Internationale d’Urologie and the Society for Urodynamics & Female Urology.
As director of the Pelvic Health and Continence Institute at Virginia Women’s Center, Dr. Green sees patients with urinary incontinence and bladder difficulties. His interest lies in all aspects of female urology, including pelvic relaxation and urinary tract infections.
Dr. Green and his wife have six children– three boys and three girls (all delivered by Virginia Women’s Center obstetricians). He enjoys skiing, physical fitness and playing jazz piano, but the vast majority of his non-work time is spent enjoying his family.
Areas of Expertise
Monash University, Alfred Hospital
Postgraduate Training-Senior Registrar Urology-Alfred Hospital (1993-1994)
Harvard Program in Urology: 1993
Brigham & Women’s Hospital, Children’s Hospital, Beth Israel Hospital, West Roxbury Veteran’s Hospital
Brigham & Women’s Hospital
Kaiser Foundation Medical Center
Los Angeles, California
UCLA School of Medicine
Los Angeles, California
University of St. Thomas
St. Paul, Minnesota
Palo Alto, California
Hospitals Affiliated With
St. Mary’s Hospital
Henrico Doctors’ Hospital
Memorial Regional Medical Center
St. Francis Medical Center
Stony Point Surgery Center
Hanover Outpatient Surgery Center
American Urological Association
International Continence Society
Richmond Academy of Medicine
la Societe Internationale d’Urologie
Society for Urodynamics & Female Urology
Temperature-Dependent Expression of a 95kD Protein in Rat Testix: 1995
Andrologia 27:107 Rubenstein, S.C., Green, L.S., Schopperle, W.M., DeWolf, W.C., Morgentaler, A.
‘Open’ Percutaneous Ultrasonic Lithotripsy For Failed Anatrophic Nephrolithotomy: 1995
Br. J. Urol. 75:249 Watson, D.L., Green, L.S., and Loughlin, K.R.
Management of Epigastric Vessel Injury During Laparoscopy: 1992
J.EndoUrol 6:99 Green, L.S., Loughlin, K.R., and Kavoussi, L.R.
Temperatured-Dependent Expression of a 95kD Protein in Rat Testis: 1991
Surgical Forum, Vol. 42 Green, L.S., Schopperle, W.M., DeWolf, W.C., and Morgentaler, A.
The Incidence of Ingested Metabisulfite Sensitivity in an Asthmatic Population : 1982
Abst, J. Alleg. Clin. Immunol. 69:118 Simon, R.A., Green, L.S., and Stevenson, D.D.
Research Experience-Principal Investigator
A Study Evaluating the Efficacy and Safety of BOTOX® and Solifenacin in Patients with Overactive Bladder and Urinary Incontinence – Allergan 191622-125 (2013)
A Pilot, Multicenter, Double-Blind, Placebo-Controlled, Dose-Escalation Study of the Safety and Efficacy of AGN 214868 in Patients with Idiopathic Overactive Bladder (IOAB) and Urinary Incontinence – Allergan 214868-004 (2010)
A Multicenter, Long-Term, Follow-up Study of the Safety and Efficacy of BOTOX® (Botulinum Toxin Type A) Purified Neurotoxin Complex in Patients with Idiopathic Overactive Bladder with Urinary Incontinence – Allergan 191622-096 (2010)
A Multicenter, Double-Blind, Randomized, Placebo-Controlled, Parallel-Group Study of the Safety and Efficacy of a Single Treatment of BOTOX® (Botulinum Toxin Type A) Purified Neurotoxin Complex Followed by a Treatment with BOTOX® as Applicable in Patients with Idiopathic Overactive Bladder with Urinary Incontinence – Allergan 191622-520 (2009)
A 12 Week, Randomized, Double-Blind, Placebo-Controlled, Parallel Group, Multicenter Study to Evaluate the Efficacy of Darifenacin 15 mg OD on Increase in Warning Time, the Time from First Sensation of Urgency to Voiding, in Patients with Overactive Bladder – Novartis CDAR328A2401 (2004)
A 12 Week Safety and Efficacy Study of ORALTAK-637 versus Placebo in Subjects with Overactive Bladder – TAP Holdings, Inc. M98-946 (2000)
A Comparison of Tolterodine versus Tolterodine and Estring in Patients with Symptoms of Urinary Urgency and Mixed Incontinence – Pharmacia & Upjohn M6490-0002 (1999)
A Multicenter, Randomized, Cohort-Controlled Study Evaluating the Safety and Effectiveness of the Male on-Command Catheter in Subjects with Lower Urinary Outflow Tract Disorders. URO-QUEST Corporation MOCC-01-95 (1998)
Medical College of Virginia Hospitals
Associate Clinical Professor with the Department of Surgery